FDA expands approval of Merck shingles vaccine - BusinessWeek

[INCIID News Feed]

Internal Medicine News Digital Network
<img alt="" height="1" width="1" />
FDA expands approval of Merck shingles vaccine
BusinessWeek
The Food and Drug Administration on Thursday expanded approval of a shingles vaccine from Merck to patients between the ages of 50 and 59. The vaccine, called Zostavax, is already approved for patients of 60 years and older. "The likelihood of shingles ...
Merck shingles vaccine gets FDA OK for more patientsInternational Business Times
FDA expands Merck shingles vaccine approvalPharmaceutical Business Review
FDA OKs shingle vaccine for those aged 50 to 59Reuters
MedPage Today -U.S. News & World Report -TopNews New Zealand
all 126 news articles &raquo;


More...